The research venture in arrhythmogenic right ventricular cardiomyopathy: a paradigm of translational medicine.

Arrhythmogenic right ventricular cardiomyopathy is a recent discovery in the field of non-ischaemic myocardial diseases. It represents a unique example on how it is possible in few years to move from the identification of a new lethal morbid entity at the anatomical theatre towards the unveiling of the genetic aetiology, thus allowing early detection of carriers with effective strategies for premature death prevention.